Researchers find a new genetic vulnerability in acute myeloid leukemia
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might…
Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities
AML has only a 29 percent survival rate, and it’s a fast-growing cancer. It’s often widespread in the…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
New study exposes a targetable vulnerability in acute myeloid leukemia
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia…
Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
Credit: Kateryna Kon/Science Photo Library/Getty Images Scientists at the University of Glasgow developed a bioengineered bone marrow (BM)…